戻る Agenda
Clinical Trials and GDPR
Session Chair(s)
Brendan Barnes
Director, Data Protection & IP
EFPIA, Belgium
In recent guidance, both the European Commission and the Article 29 Committee overseeing the GDPR have suggested that consent should not be the preferred basis for processing data in clinical trials. This panel will explore why this view was reached and what its implications are for the conduct of research and relations with research participants. We will in particular look at how the ethical and legal safeguards that govern clinical research, viewed from the perspective of the privacy regulator, and how these relate to the principle of accountability under GDPR.
Speaker(s)
The View of the Privacy Regulator
Joao Soares da Silva, MA
European Data Protection Board, Belgium
Legal officer / DPO
Company Experience in Adapting to the New Requirements
Lee Parker, JD, LLM
Biogen International Gmbh, Switzerland
Director EU+ Privacy
What do Trial Participants and Patients Think?
Souzi Makri
Cyprus League Against Rheumatism , Cyprus
Vice-President